This supplement to The American Journal of Managed Care includes information on how bipolar disorder affects quality of life and the impact of misdiagnosis. This program has been peer reviewed by experts in the field.
Faculty Robert M. A. Hirschfeld, MD
Titus H. Harris Chair
Professor and Chair
Department of Psychiatry and Behavioral Sciences
University of Texas Medical Branch
Galveston, Texas
Roy H. Perlis, MD
Instructor of Psychiatry
Harvard Medical School
Boston, Massachusetts
Lana A. Vornik, MSc
Senior Research Associate
Department of Psychiatry and Behavioral Sciences
University of Texas Medical Branch
Galveston, Texas
Faculty Disclosure
It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.
These participants report relationships with the following pharmaceutical companies:
- Robert M. A. Hirschfeld, MD
Consultant/advisory board member to:
- Abbott Laboratories
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Forest Laboratories
- GlaxoSmithKline
- Janssen
- Novartis
- Organon
- Pfizer
- Shire
- UCB Pharma
- Wyeth-Ayerst
- Lana A. Vornik, MSc
- Roy H. Perlis, MD
Honoraria or consulting fees from:
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- GlaxoSmithKline
- Pfizer
Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.
This supplement has been supported by funding from AstraZeneca Pharmaceuticals.
•••
The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.
|
